Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Yu-Wei Zhao"'
Publikováno v:
Metabolites, Vol 14, Iss 11, p 590 (2024)
Background/Objectives: Fritillaria taipaiensis P.Y. Li is a valuable traditional Chinese medicinal herb that utilizes bulbs as medicine, which contain multiple alkaloids. Biomass, as a sustainable resource, has promising applications in energy, envir
Externí odkaz:
https://doaj.org/article/9471e0da63944e9db378d87cfb46a5ee
Autor:
Zhong-Ning He, Chun-Yu Zhang, Yu-Wei Zhao, Shu-Lin He, Yue Li, Bo-Lun Shi, Jia-Qi Hu, Run-Zhi Qi, Bao-Jin Hua
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-22 (2023)
Abstract Myeloid-derived suppressor cells (MDSCs), major components maintaining the immune suppressive microenvironment in lung cancer, are relevant to the invasion, metastasis, and poor prognosis of lung cancer, through the regulation of epithelial-
Externí odkaz:
https://doaj.org/article/fca3791228e7439183b877b9a2e3a21f
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
Aim: Combined use of herbal medicines in patients underwent dual antiplatelet therapy (DAPT) might cause bleeding or thrombosis because herbal medicines with anti-platelet activities may exhibit interactions with DAPT. In this study, we tried to use
Externí odkaz:
https://doaj.org/article/0edc129ac7c644b9af703602c1587bd7
Autor:
Qiong-wen Zhang, Lei Liu, Chang-yang Gong, Hua-shan Shi, Yun-hui Zeng, Xiao-ze Wang, Yu-wei Zhao, Yu-quan Wei
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50946 (2012)
PURPOSE: Tumor associated macrophages (TAMs) are considered with the capacity to have both negative and positive effects on tumor growth. The prognostic value of TAM for survival in patients with solid tumor remains controversial. EXPERIMENTAL DESIGN
Externí odkaz:
https://doaj.org/article/19d9fa31d171449fb07942e3fd6e4a06
Autor:
Xing-chen Peng, Feng-ming Gong, Yu-wei Zhao, Liang-xue Zhou, Ying-wei Xie, Hong-li Liao, Hong-jun Lin, Zhi-yong Li, Ming-hai Tang, Ai-ping Tong
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27309 (2011)
Lung cancer is the leading cause of cancer-related death in the world. Non-small cell lung carcinomas (Non-SCLC) account for almost 80% of lung cancers, of which 40% were adenocarcinomas. For a better understanding of the molecular mechanisms behind
Externí odkaz:
https://doaj.org/article/d70aad07a5a143c5a7f9fad1dd1d3c7d
Publikováno v:
Frontiers in Oncology; 2024, p1-5, 5p
Autor:
Chen Ling, Su-Su Liu, Yu-Ya Wang, Gui-Tao Huo, Yan-Wei Yang, Nan Xu, Hong Wang, Yong Wu, Yu- Fa Miao, Rui Fu, Yu-Wei Zhao, Chang-Fa Fan
Publikováno v:
Zoological Research; 2024, Vol. 45 Issue 3, p551-566, 16p
Autor:
Fan Tang, Yu-Wei Zhao, Yu Ge, Yong-Gang Sun, Yu Zhang, Xiu-Lin Yang, An-Min Cao, Jian-Hua Qiu, Xi-Jie Lin
Publikováno v:
Journal of Colloid and Interface Science. 628:524-533
Autor:
Yu Wei Zhao, Song Liu, Hao Qin, Jin Bo Sun, Mao Su, Guang Ji Yu, Jun Zhou, Fei Gao, Ruo Yu Wang, Tong Zhao, Guang Sheng Zhao
Publikováno v:
Frontiers in Oncology. 13
ObjectiveThis study aimed to prospectively observe the efficacy and safety of CalliSpheres drug-eluting beads bronchial arterial chemoembolization (DEB-BACE) for refractory non-small-cell lung cancer (NSCLC).MethodsThe interventional therapy plan was
Autor:
Run-Zhi, Qi, Shu-Lin, He, Yue, Li, Yu-Wei, Zhao, Liang, Geng, Jie, He, Meng-Qi, Cheng, Jia-Qi, Hu, Cong-Huang, Li, Bao-Jin, Hua
Publikováno v:
Chinese Journal of Integrative Medicine.
To investigate the efficacy of integrated Chinese and Western medicine extending the progression-free survival (PFS) and overall survival (OS) of limited-stage small cell lung cancer (LS-SCLC) patients after the first-line chemoradiotherapy.The data